Guggenheim Capital’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$636K Sell
2025
Q2
$664K Sell
2025
Q1
$717K Buy
2024
Q4
$914K Buy
2024
Q3
$1.05M Sell
2024
Q2
$991K Buy
2024
Q1
$1.11M Buy
2023
Q4
$1.17M Buy